Shenzhen Chipscreen Biosciences Co (688321) — Free Cash Flow Generation Index

Latest as of September 2025: -26.48x

Shenzhen Chipscreen Biosciences Co (688321) has a Free Cash Flow Generation Index of -26.48x as of September 2025. Free cash flow of CN¥-59.48 Million represents -26% of operating cash flow (CN¥2.25 Million). See working capital position of Shenzhen Chipscreen Biosciences Co to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-26.48x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-59.48 Million
CNY

Operating Cash Flow

CN¥2.25 Million
CNY

Capital Expenditures

CN¥61.73 Million
CNY

Shenzhen Chipscreen Biosciences Co Free Cash Flow Generation Index (2016–2024)

Historical FCF Generation Index trend for Shenzhen Chipscreen Biosciences Co across 7 annual periods. Explore how well can Shenzhen Chipscreen Biosciences Co service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Shenzhen Chipscreen Biosciences Co (2016–2024)

Year-by-year Free Cash Flow Generation Index for Shenzhen Chipscreen Biosciences Co. For the full company profile including market capitalisation, see how much is Shenzhen Chipscreen Biosciences Co worth.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -2.53x CN¥-192.36 Million CN¥76.13 Million CN¥268.49 Million ▲ +69.3%
2022 -8.24x CN¥-356.87 Million CN¥43.30 Million CN¥400.17 Million ▼ -528.4%
2021 -1.31x CN¥-163.68 Million CN¥124.78 Million CN¥288.46 Million ▲ +49.4%
2020 -2.59x CN¥-242.65 Million CN¥93.62 Million CN¥336.27 Million ▲ +49.9%
2018 -5.18x CN¥-117.96 Million CN¥22.78 Million CN¥140.74 Million ▲ +89.1%
2017 -47.65x CN¥-130.09 Million CN¥2.73 Million CN¥132.82 Million ▼ -47043.9%
2016 -0.10x CN¥-6.04 Million CN¥59.77 Million CN¥65.81 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).